Morgan Stanley highlighted 14 stocks for which the firm believes that "one or more imminent events will drive the share price materially over the next 15-60 days," according to a July 18 note to clients.

For each of the 14 stocks, the covering Morgan Stanley equity analyst has "high conviction in a view that diverges from the Street's" and identifies a near-term event, primarily quarterly earnings results, that could drive the stock higher or lower. The report listed nine stocks for which the covering analyst has identified positive potential stock catalysts and five with negative potential stock drivers.

But how does the technical analysis of each stock stack up? TheStreet paired the Morgan Stanley's fundamental analysis with technical analysis from Bruce Kamich, our in-house chartist.

Here are Morgan Stanley's negative catalyst picks paired with Kamich's technical analysis. TheStreet excluded Relypsa (RLYP) from Morgan Stanley's negative catalyst list due to the news on Thursday that the biotech will be acquired by Galencia for $1.53 billion.

TheStreet Recommends